My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 316

    1.

    Acute effect of glimepiride on insulin-stimulated glucose metabolism in glucose-tolerant insulin-resistant offspring of patients with type 2 diabetes.

    Overkamp D, Volk A, Maerker E, Heide PE, Wahl HG, Rett K, Häring HU.

    Diabetes Care. 2002 Nov;25(11):2065-73.PMID: 12401758 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    The effect of glimepiride on pancreatic beta-cell function under hyperglycaemic clamp and hyperinsulinaemic, euglycaemic clamp conditions in non-insulin-dependent diabetes mellitus.

    Clark HE, Matthews DR.

    Horm Metab Res. 1996 Sep;28(9):445-50.PMID: 8911981 [PubMed - indexed for MEDLINE]Related articles

    3.

    Effects of pioglitazone and glimepiride on glycemic control and insulin sensitivity in Mexican patients with type 2 diabetes mellitus: A multicenter, randomized, double-blind, parallel-group trial.

    Tan M, Johns D, González Gálvez G, Antúnez O, Fabián G, Flores-Lozano F, Zúñiga Guajardo S, Garza E, Morales H, Konkoy C, Herz M; GLAD Study Group.

    Clin Ther. 2004 May;26(5):680-93.PMID: 15220012 [PubMed - indexed for MEDLINE]Related articles

    4.

    Improved insulin action and glycemic control after long-term angiotensin-converting enzyme inhibition in subjects with arterial hypertension and type II diabetes.

    Torlone E, Britta M, Rambotti AM, Perriello G, Santeusanio F, Brunetti P, Bolli GB.

    Diabetes Care. 1993 Oct;16(10):1347-55.PMID: 8269792 [PubMed - indexed for MEDLINE]Related articles

    5.

    Short-term comparison of once- versus twice-daily administration of glimepiride in patients with non-insulin-dependent diabetes mellitus.

    Sonnenberg GE, Garg DC, Weidler DJ, Dixon RM, Jaber LA, Bowen AJ, DeChemey GS, Mullican WS, Stonesifer LD.

    Ann Pharmacother. 1997 Jun;31(6):671-6.PMID: 9184703 [PubMed - indexed for MEDLINE]Related articles

    6.

    Glimepiride improves both first and second phases of insulin secretion in type 2 diabetes.

    Korytkowski M, Thomas A, Reid L, Tedesco MB, Gooding WE, Gerich J.

    Diabetes Care. 2002 Sep;25(9):1607-11.PMID: 12196435 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Effects of glimepiride on in vivo insulin action in normal and diabetic rats.

    Sato J, Ohsawa I, Oshida Y, Sato Y, Sakamoto N.

    Diabetes Res Clin Pract. 1993 Oct-Nov;22(1):3-9.PMID: 8137714 [PubMed - indexed for MEDLINE]Related articles

    8.

    Effects of 1 year of treatment with pioglitazone or rosiglitazone added to glimepiride on lipoprotein (a) and homocysteine concentrations in patients with type 2 diabetes mellitus and metabolic syndrome: a multicenter, randomized, double-blind, controlled clinical trial.

    Derosa G, Cicero AF, D'Angelo A, Gaddi A, Ciccarelli L, Piccinni MN, Salvadeo SA, Pricolo F, Ferrari I, Gravina A, Ragonesi PD.

    Clin Ther. 2006 May;28(5):679-88. Erratum in: Clin Ther. 2006 Sep;28(9):1483. PMID: 16861090 [PubMed - indexed for MEDLINE]Related articles

    9.

    Triple therapy with glimepiride in patients with type 2 diabetes mellitus inadequately controlled by metformin and a thiazolidinedione: results of a 30-week, randomized, double-blind, placebo-controlled, parallel-group study.

    Roberts VL, Stewart J, Issa M, Lake B, Melis R.

    Clin Ther. 2005 Oct;27(10):1535-47.PMID: 16330290 [PubMed - indexed for MEDLINE]Related articles

    10.

    Repaglinide is more efficient than glimepiride on insulin secretion and post-prandial glucose excursions in patients with type 2 diabetes. A short term study.

    Rizzo MR, Barbieri M, Grella R, Passariello N, Barone M, Paolisso G.

    Diabetes Metab. 2004 Feb;30(1):81-9.PMID: 15029102 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Effects of glimepiride and glyburide on glucose counterregulation and recovery from hypoglycemia.

    Szoke E, Gosmanov NR, Sinkin JC, Nihalani A, Fender AB, Cryer PE, Meyer C, Gerich JE.

    Metabolism. 2006 Jan;55(1):78-83.PMID: 16324923 [PubMed - indexed for MEDLINE]Related articles

    12.

    Comparison of the effects of pioglitazone and metformin on hepatic and extra-hepatic insulin action in people with type 2 diabetes.

    Basu R, Shah P, Basu A, Norby B, Dicke B, Chandramouli V, Cohen O, Landau BR, Rizza RA.

    Diabetes. 2008 Jan;57(1):24-31. Epub 2007 Oct 3.PMID: 17914032 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Free fatty acids reduce splanchnic and peripheral glucose uptake in patients with type 2 diabetes.

    Bajaj M, Pratipanawatr T, Berria R, Pratipanawatr W, Kashyap S, Cusi K, Mandarino L, DeFronzo RA.

    Diabetes. 2002 Oct;51(10):3043-8.PMID: 12351445 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    The effects of acute exercise on metabolic control in type II diabetic patients treated with glimepiride or glibenclamide.

    Massi-Benedetti M, Herz M, Pfeiffer C.

    Horm Metab Res. 1996 Sep;28(9):451-5.PMID: 8911982 [PubMed - indexed for MEDLINE]Related articles

    15.

    Pharmacokinetic and pharmacodynamic modelling of the effects of glimepiride on insulin secretion and glucose lowering in healthy humans.

    Yun HY, Park HC, Kang W, Kwon KI.

    J Clin Pharm Ther. 2006 Oct;31(5):469-76.PMID: 16958825 [PubMed - indexed for MEDLINE]Related articles

    16.

    Metabolic effects of pioglitazone and rosiglitazone in patients with diabetes and metabolic syndrome treated with glimepiride: a twelve-month, multicenter, double-blind, randomized, controlled, parallel-group trial.

    Derosa G, Cicero AF, Gaddi A, Ragonesi PD, Fogari E, Bertone G, Ciccarelli L, Piccinni MN.

    Clin Ther. 2004 May;26(5):744-54.PMID: 15220018 [PubMed - indexed for MEDLINE]Related articles

    17.

    Insulin-like growth factor I has a direct effect on glucose and protein metabolism, but no effect on lipid metabolism in type 1 diabetes.

    Simpson HL, Jackson NC, Shojaee-Moradie F, Jones RH, Russell-Jones DL, Sönksen PH, Dunger DB, Umpleby AM.

    J Clin Endocrinol Metab. 2004 Jan;89(1):425-32.PMID: 14715881 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Sulfonylurea therapy fails to diminish insulin resistance in type I-diabetic subjects.

    Keller U, Müller R, Berger W.

    Horm Metab Res. 1986 Sep;18(9):599-603.PMID: 2946637 [PubMed - indexed for MEDLINE]Related articles

    19.

    Overnight normalization of glucose concentrations improves hepatic but not extrahepatic insulin action in subjects with type 2 diabetes mellitus.

    Wise SD, Nielsen MF, Cryer PE, Rizza RA.

    J Clin Endocrinol Metab. 1998 Jul;83(7):2461-9.PMID: 9661629 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Circulating endothelin-1 levels increase during euglycemic hyperinsulinemic clamp in lean NIDDM men.

    Ferri C, Carlomagno A, Coassin S, Baldoncini R, Cassone Faldetta MR, Laurenti O, Properzi G, Santucci A, De Mattia G.

    Diabetes Care. 1995 Feb;18(2):226-33.PMID: 7729302 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity